Results 61 to 70 of about 10,158,480 (212)

Diagnosis of Portal Hypertension: Advancing Towards Non‐Invasive Solutions

Portal Hypertension &Cirrhosis, EarlyView.
This review systematically summarizes a full spectrum of non‐invasive diagnostic approaches for portal hypertension (PH), including imaging modalities, elastography, serum biomarkers, composite scoring systems and endoscopic ultrasound‐guided portal pressure gradient (EUS‐PPG), and analyzes their performance across different liver disease etiologies ...
Lijia Yin, Huikuan Chu, Ling Yang
wiley   +1 more source

Balloon Tamponade and Esophageal Stenting for Esophageal Variceal Bleeding in Cirrhosis: A Systematic Review and Meta-analysis.

, 2019
Failure to control variceal bleeding with current recommendations occurs in 10 to 20% of cases. This systematic review and meta-analysis analyzes the experience, results, and complications of "bridge" therapies for failure to control acute variceal ...
Bosch, Jaime, Escorsell, Àngels, Cárdenas, Andrés, G. Rodrigues, Susana   +3 more
core   +1 more source

Gastric Variceal Bleeding in the Elderly [PDF]

, 2012
SummaryBackgroundUpper gastrointestinal bleeding of all causes has a higher morbidity and mortality in older patients compared with younger patients. We retrospectively studied gastric variceal bleeding in older patients and compared the complications ...
Chih-Jen Chen, Tsang-En Wang, Shee-Chan Lin, Sun, Fang-Ju, Wang, Tsang-En, Chen, Chih-Jen, Fang-Ju Sun, Wang, Horng-Yuan, Chen, Ming-Jen, Ming-Jen Chen, Shih, Shou-Chuan, Liu, Chia-Yuan, Chia-Yuan Liu, Shou-Chuan Shih, Lin, Ching-Chung, Ching-Chung Lin, Horng-Yuan Wang, Lin, Shee-Chan   +17 more
core   +1 more source

Characteristics of myeloproliferative neoplasm-associated portal hypertension and endoscopic management of variceal bleeding

Therapeutic Advances in Chronic Disease, 2022
Background: Myeloproliferative neoplasms (MPNs) are a rare yet important clinical cause of portal hypertension, which may cause recurrent gastroesophageal variceal bleeding (GVB).
Xiaoquan Huang, Ming Zhang, Yingjie Ai, Siyu Jiang, Mei Xiao, Lifen Wang, Yourong Jian, Yuzheng Zhuge, Chunqing Zhang, Shiyao Chen   +9 more
doaj   +1 more source

Prognostic significance of prior alcohol use disorder in patients with presumed metabolic dysfunction‐associated steatotic liver disease: A large multi‐center cohort study

Addiction, EarlyView.
Abstract Background and aims Alcohol use disorder (AUD) follows a chronic, relapsing course but is often overlooked when alcohol consumption is minimal at the time of evaluation. We aimed to assess the prognostic impact of a prior AUD diagnosis on liver‐related outcomes in patients with presumed metabolic dysfunction‐associated steatotic liver disease (
Butros Fakhoury, Jinye Liu, Vinay Jahagirdar, Kaanthi Rama, Gerald Scott Winder, Luis Antonio Díaz, Juan Pablo Arab   +6 more
wiley   +1 more source

Review of embolic materials for gastrointestinal bleeding embolization

International Journal of Gastrointestinal Intervention
Acute non-variceal gastrointestinal (GI) bleeding is a common and potentially life-threatening condition encountered in clinical practice. Transcatheter arterial embolization (TAE) has emerged as a widely accepted and effective therapeutic option for ...
Jin Hyeok Kim
doaj   +1 more source

Clinical Outcomes After Percutaneous Coronary Intervention in Patients With Cirrhosis: A Multicentre National Study

Alimentary Pharmacology &Therapeutics, EarlyView.
Summary of a multicentre TriNetX study evaluating outcomes after percutaneous coronary intervention (PCI) in patients with cirrhosis. Cirrhosis was associated with higher 1‐year gastrointestinal bleeding and mortality, especially with decompensated disease.
Dhir Gala, Sameer Rao, Manas Gunani, Kajol Shah, Anand V. Kulkarni, Karn Wijarnpreecha, Daniel Q. Huang, Pojsakorn Danpanichkul, Ahmed Al‐Khazraji, Kaveh Hajifathalian, Vivek Lingiah, Paul Gaglio, Nikki Duong, Christine Gerula   +13 more
wiley   +1 more source

Review Article: Fibrosis Reversal in Metabolic Dysfunction‐Associated Steatohepatitis—The Promise of Emerging Therapeutics

Alimentary Pharmacology &Therapeutics, EarlyView.
Metabolic dysfunction‐associated steatohepatitis is the second commonest US indication for liver transplantation but remains largely undiagnosed and untreated. Fibrosis stage is the strongest predictor of major adverse liver outcomes, with decompensation rates and transplant‐free survival diverging sharply between F3 and F4, while cardiovascular ...
Malek Ayoub, Tsubasa Tsutsumi, Mary E. Rinella   +2 more
wiley   +1 more source

Frequency of In-Hospital Mortality in Patients with Upper Gastrointestinal Bleeding (UGIB) Due to Liver Cirrhosis

Pakistan Journal of Medicine and Dentistry
Background: Upper Gastrointestinal haemorrhage is a common medical emergency, and a fatality in liver cirrhosis patients The most common complication of portal hypertension in liver cirrhosis patients is esophageal variceal bleeding.
Mehwish Dilber, Abdul Aziz Sahito, Waseem Raja Memon, Zafar Ullah Phul, Muhammad Zarrar, Riaz Hussain Khokhar   +5 more
doaj   +1 more source

Pruritus Is Frequent and Persistent and Impacts Quality of Life Among Patients With Primary Sclerosing Cholangitis

Alimentary Pharmacology &Therapeutics, EarlyView.
Among 200 patients with primary sclerosing cholangitis, 38% reported moderate to severe pruritus in the past 6 months. During 6 months of follow up, pruritus severity fluctuated significantly. Pruritus severity was linked to worse colitis activity and lower quality of life.
Richard Dean, Maryam Yazdanfar, Joseph Zepeda, Isha J. Patel, Cynthia Levy, Craig Lammert, Raghav Bordia, Duru Cosar, Katherine Specht, Daniel Pratt, Stuart C. Gordon, Lisa Forman, Fawzy Barry, Michael Li, Usha Gungabissoon, Megan M. McLaughlin, Christopher L. Bowlus   +16 more
wiley   +1 more source